Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GLAXOSMITHKLINE : UBS sticks Neutral

08/03/2021 | 06:09am EDT

In his latest research note, analyst Laura Sutcliffe confirms his recommendation. The broker UBS is keeping its Neutral rating. The target price has been modified and is now set at GBX 1485 compared to GBX 1500.


© MarketScreener with dpa-AFX Analyser 2021
All news about GLAXOSMITHKLINE PLC
09/17Glaxosmithkline plc Receives CHMP Positive Opinions Recommending Approval of ..
CI
09/17GLAXOSMITHKLINE : Receives Positive Marketing Recommendation From European Medic..
MT
09/17GLAXOSMITHKLINE : GSK Lands Positive Opinion From European Medicines Agency for ..
MT
09/17GLAXOSMITHKLINE : GSK receives CHMP positive opinions recommending approval of N..
PU
09/15PharmaSGP Holding SE raises forecast for FY 2021 following completion of acqu..
DJ
09/15CROSSWORD CYBERSECURITY PLC : Appointments URENCO CISO to Advisory Board
AQ
09/15CureVac Cancels mRNA Contracts For COVID-19 Jab
MT
09/14GLAXOSMITHKLINE : Deutsche Bank reiterates its Neutral rating
MD
09/13GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
09/09GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
More news
Analyst Recommendations on GLAXOSMITHKLINE PLC
More recommendations
Financials
Sales 2021 33 310 M 45 761 M 45 761 M
Net income 2021 3 861 M 5 305 M 5 305 M
Net Debt 2021 20 884 M 28 690 M 28 690 M
P/E ratio 2021 18,1x
Yield 2021 5,76%
Capitalization 69 478 M 95 560 M 95 450 M
EV / Sales 2021 2,71x
EV / Sales 2022 2,53x
Nbr of Employees 94 066
Free-Float 92,2%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 1 388,20 GBX
Average target price 1 608,27 GBX
Spread / Average Target 15,9%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC3.44%95 560
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604